Tandem Diabetes Care’s iOS and Android apps connect to the t: slim X2 insulin pump.
The Food and Drug Administration (FDA) has approved Tandem Diabetes Care’s smartphone app for programming and canceling insulin doses from the t:slim X2 insulin pump. According to the company, this is the first time the FDA has approved a phone app for this purpose.
According to Tandem Diabetes Care, the t:connect mobile app for iOS and Android will allow users to program and cancel bolus insulin doses from the pump. When connected to the pump, the app can show glucose trends, changes in status (including alerts and alarms), and insulin therapy data for the previous 24 hours.
- Amazon is matching Samsung’s pre-order discount on Galaxy S22 smartphones
- Barcelona 1-1 Napoli: Torres penalty saves the Blaugrana from wasting their chances.
The FDA clearance could be a step toward a more convenient way for diabetes patients to administer insulin doses. Tandem Diabetes Care plans to offer the feature at no extra cost to new and in-warranty t:slim X2 insulin pump customers via a software update. The plan is to grant access to a limited number of users in the spring ahead of a broader rollout this summer.
